assessing chemotherapy and immunotherapy in dmmr endometrial cancer
Published 7 months ago • 89 plays • Length 0:47Download video MP4
Download video MP3
Similar videos
-
1:08
implications of phase iii trials in endometrial cancer: dmmr patients and immunotherapy
-
1:42
improving responses to immunotherapy for patients with endometrial cancer
-
0:50
role of immunotherapy in advanced endometrial cancer: recent developments and future directions
-
3:24
endometrial cancer health outcomes: pembrolizumab for patients with msi-high endometrial cancer
-
3:28
keynote-775 subgroup analysis in advanced endometrial cancer
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
5:23
latest developments in immunotherapy for advanced/recurrent endometrial cancer
-
0:49
research priorities for metastatic endometrial cancer
-
2:59
chemotherapy in combination with immunotherapy for the treatment of metastatic thymic carcinoma
-
1:00
precision oncology in endometrial cancer
-
0:37
importance of understanding molecular subtypes in endometrial cancer
-
2:56
keynote-177: final pfs analysis of pembrolizumab in patients with msi-h/dmmr mcrc
-
8:20
immune checkpoint inhibitors for endometrial and cervical cancer
-
1:10
deep learning risk prediction model of distant recurrence from h&e endometrial cancer slides
-
1:22
dr. zamarin on the role of pembrolizumab in endometrial cancer
-
3:13
updates in endometrial cancer at esmo 2023: attend and ruby
-
0:50
combinatorial parpi therapies in advanced endometrial cancer
-
1:10
matching treatment to molecular profiles in endometrial cancer
-
2:01
endola: olaparib, metronomic cyclophosphamide and metformin in advanced endometrial cancer